Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |